vs
Orthofix Medical Inc.（OFIX）与ONESPAWORLD HOLDINGS Ltd（OSW）财务数据对比。点击上方公司名可切换其他公司
ONESPAWORLD HOLDINGS Ltd的季度营收约是Orthofix Medical Inc.的1.1倍（$242.1M vs $219.9M），ONESPAWORLD HOLDINGS Ltd净利率更高（5.0% vs -1.0%，领先6.0%），ONESPAWORLD HOLDINGS Ltd同比增速更快（11.5% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $14.9M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 7.1%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
OFIX vs OSW — 直观对比
营收规模更大
OSW
是对方的1.1倍
$219.9M
营收增速更快
OSW
高出9.5%
2.0%
净利率更高
OSW
高出6.0%
-1.0%
自由现金流更多
OFIX
多$1.9M
$14.9M
两年增速更快
OFIX
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $242.1M |
| 净利润 | $-2.2M | $12.1M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | 6.8% |
| 净利率 | -1.0% | 5.0% |
| 营收同比 | 2.0% | 11.5% |
| 净利润同比 | 92.4% | -16.2% |
| 每股收益（稀释后） | $-0.05 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXOSW
| Q4 25 | $219.9M | $242.1M | ||
| Q3 25 | $205.6M | $258.5M | ||
| Q2 25 | $203.1M | $240.7M | ||
| Q1 25 | $193.6M | $219.6M | ||
| Q4 24 | $215.7M | $217.2M | ||
| Q3 24 | $196.6M | $241.7M | ||
| Q2 24 | $198.6M | $224.9M | ||
| Q1 24 | $188.6M | $211.2M |
净利润OFIXOSW
| Q4 25 | $-2.2M | $12.1M | ||
| Q3 25 | $-22.8M | $24.3M | ||
| Q2 25 | $-14.1M | $19.9M | ||
| Q1 25 | $-53.1M | $15.3M | ||
| Q4 24 | $-29.1M | $14.4M | ||
| Q3 24 | $-27.4M | $21.6M | ||
| Q2 24 | $-33.4M | $15.8M | ||
| Q1 24 | $-36.0M | $21.2M |
毛利率OFIXOSW
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXOSW
| Q4 25 | 0.2% | 6.8% | ||
| Q3 25 | -8.3% | 10.2% | ||
| Q2 25 | -7.9% | 9.2% | ||
| Q1 25 | -25.2% | 7.7% | ||
| Q4 24 | -5.3% | 7.9% | ||
| Q3 24 | -9.6% | 10.3% | ||
| Q2 24 | -12.5% | 8.4% | ||
| Q1 24 | -15.6% | 8.0% |
净利率OFIXOSW
| Q4 25 | -1.0% | 5.0% | ||
| Q3 25 | -11.1% | 9.4% | ||
| Q2 25 | -6.9% | 8.3% | ||
| Q1 25 | -27.4% | 7.0% | ||
| Q4 24 | -13.5% | 6.6% | ||
| Q3 24 | -13.9% | 8.9% | ||
| Q2 24 | -16.8% | 7.0% | ||
| Q1 24 | -19.1% | 10.0% |
每股收益（稀释后）OFIXOSW
| Q4 25 | $-0.05 | $0.12 | ||
| Q3 25 | $-0.57 | $0.23 | ||
| Q2 25 | $-0.36 | $0.19 | ||
| Q1 25 | $-1.35 | $0.15 | ||
| Q4 24 | $-0.76 | $0.13 | ||
| Q3 24 | $-0.71 | $0.20 | ||
| Q2 24 | $-0.88 | $0.15 | ||
| Q1 24 | $-0.95 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $16.3M |
| 总债务越低越好 | — | $84.0M |
| 股东权益账面价值 | $450.0M | $542.6M |
| 总资产 | $850.6M | $707.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资OFIXOSW
| Q4 25 | $82.0M | $16.3M | ||
| Q3 25 | $62.9M | $29.6M | ||
| Q2 25 | $65.6M | $35.0M | ||
| Q1 25 | $58.0M | $22.6M | ||
| Q4 24 | $83.2M | $57.4M | ||
| Q3 24 | $30.1M | $48.8M | ||
| Q2 24 | $26.4M | $62.5M | ||
| Q1 24 | $27.0M | $65.4M |
总债务OFIXOSW
| Q4 25 | — | $84.0M | ||
| Q3 25 | $157.2M | $85.2M | ||
| Q2 25 | $157.0M | $96.2M | ||
| Q1 25 | $156.9M | $97.4M | ||
| Q4 24 | $157.0M | $98.6M | ||
| Q3 24 | $118.5M | $98.7M | ||
| Q2 24 | $118.0M | $123.8M | ||
| Q1 24 | $118.2M | $138.6M |
股东权益OFIXOSW
| Q4 25 | $450.0M | $542.6M | ||
| Q3 25 | $442.5M | $552.8M | ||
| Q2 25 | $458.3M | $548.3M | ||
| Q1 25 | $458.3M | $530.6M | ||
| Q4 24 | $503.1M | $554.5M | ||
| Q3 24 | $525.9M | $540.1M | ||
| Q2 24 | $546.0M | $532.7M | ||
| Q1 24 | $570.3M | $515.5M |
总资产OFIXOSW
| Q4 25 | $850.6M | $707.1M | ||
| Q3 25 | $832.6M | $732.6M | ||
| Q2 25 | $837.2M | $731.8M | ||
| Q1 25 | $823.1M | $708.7M | ||
| Q4 24 | $893.3M | $746.4M | ||
| Q3 24 | $867.9M | $734.0M | ||
| Q2 24 | $882.0M | $756.8M | ||
| Q1 24 | $906.0M | $763.6M |
负债/权益比OFIXOSW
| Q4 25 | — | 0.15× | ||
| Q3 25 | 0.36× | 0.15× | ||
| Q2 25 | 0.34× | 0.18× | ||
| Q1 25 | 0.34× | 0.18× | ||
| Q4 24 | 0.31× | 0.18× | ||
| Q3 24 | 0.23× | 0.18× | ||
| Q2 24 | 0.22× | 0.23× | ||
| Q1 24 | 0.21× | 0.27× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $20.0M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $14.9M |
| 自由现金流率自由现金流/营收 | 7.6% | 6.2% |
| 资本支出强度资本支出/营收 | 4.9% | 2.1% |
| 现金转化率经营现金流/净利润 | — | 1.65× |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $68.4M |
8季度趋势，按日历期对齐
经营现金流OFIXOSW
| Q4 25 | $27.7M | $20.0M | ||
| Q3 25 | $12.4M | $33.2M | ||
| Q2 25 | $11.6M | $20.3M | ||
| Q1 25 | $-18.4M | $10.1M | ||
| Q4 24 | $23.7M | $16.6M | ||
| Q3 24 | $11.7M | $28.6M | ||
| Q2 24 | $9.0M | $18.7M | ||
| Q1 24 | $-18.6M | $15.0M |
自由现金流OFIXOSW
| Q4 25 | $16.8M | $14.9M | ||
| Q3 25 | $2.5M | $27.6M | ||
| Q2 25 | $4.5M | $17.6M | ||
| Q1 25 | $-25.1M | $8.4M | ||
| Q4 24 | $15.2M | $13.2M | ||
| Q3 24 | $6.3M | $27.5M | ||
| Q2 24 | $-360.0K | $17.6M | ||
| Q1 24 | $-29.1M | $13.7M |
自由现金流率OFIXOSW
| Q4 25 | 7.6% | 6.2% | ||
| Q3 25 | 1.2% | 10.7% | ||
| Q2 25 | 2.2% | 7.3% | ||
| Q1 25 | -13.0% | 3.8% | ||
| Q4 24 | 7.0% | 6.1% | ||
| Q3 24 | 3.2% | 11.4% | ||
| Q2 24 | -0.2% | 7.8% | ||
| Q1 24 | -15.4% | 6.5% |
资本支出强度OFIXOSW
| Q4 25 | 4.9% | 2.1% | ||
| Q3 25 | 4.8% | 2.2% | ||
| Q2 25 | 3.5% | 1.1% | ||
| Q1 25 | 3.5% | 0.8% | ||
| Q4 24 | 4.0% | 1.5% | ||
| Q3 24 | 2.7% | 0.5% | ||
| Q2 24 | 4.7% | 0.5% | ||
| Q1 24 | 5.6% | 0.6% |
现金转化率OFIXOSW
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 1.15× | ||
| Q3 24 | — | 1.33× | ||
| Q2 24 | — | 1.19× | ||
| Q1 24 | — | 0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
OSW
| Services | $197.3M | 82% |
| Products | $44.8M | 18% |
